165 related articles for article (PubMed ID: 32980549)
1. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
Mehta M; Satija S; Paudel KR; Malyla V; Kannaujiya VK; Chellappan DK; Bebawy M; Hansbro PM; Wich PR; Dua K
Nanomedicine; 2021 Jan; 31():102303. PubMed ID: 32980549
[TBL] [Abstract][Full Text] [Related]
2. miRNA nanotherapeutics: potential and challenges in respiratory disorders.
Mehta M; Chellappan DK; Wich PR; Hansbro NG; Hansbro PM; Dua K
Future Med Chem; 2020 Jun; 12(11):987-990. PubMed ID: 32270706
[No Abstract] [Full Text] [Related]
3. Spatiotemporal control of microRNA function using light-activated antagomirs.
Connelly CM; Uprety R; Hemphill J; Deiters A
Mol Biosyst; 2012 Nov; 8(11):2987-93. PubMed ID: 22945263
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.
Kardani A; Yaghoobi H; Alibakhshi A; Khatami M
J Cell Physiol; 2020 Oct; 235(10):6887-6895. PubMed ID: 32003016
[TBL] [Abstract][Full Text] [Related]
5. Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.
Simion V; Nadim WD; Benedetti H; Pichon C; Morisset-Lopez S; Baril P
Curr Neuropharmacol; 2017; 15(2):276-290. PubMed ID: 27397479
[TBL] [Abstract][Full Text] [Related]
6. Antagonists of the miRNA-Argonaute 2 Protein Complex: Anti-miR-AGOs.
Schmidt MF; Korb O; Abell C
Methods Mol Biol; 2017; 1517():239-249. PubMed ID: 27924487
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of antagomiRs in haematological and oncological neoplasms.
Innao V; Allegra A; Pulvirenti N; Allegra AG; Musolino C
Eur J Cancer Care (Engl); 2020 Mar; 29(2):e13208. PubMed ID: 31899849
[TBL] [Abstract][Full Text] [Related]
8. Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models.
Murdaca G; Tonacci A; Negrini S; Greco M; Borro M; Puppo F; Gangemi S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412612
[TBL] [Abstract][Full Text] [Related]
9. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).
Gambari R; Brognara E; Spandidos DA; Fabbri E
Int J Oncol; 2016 Jul; 49(1):5-32. PubMed ID: 27175518
[TBL] [Abstract][Full Text] [Related]
10. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
Bertoli G; Cava C; Castiglioni I
Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
[TBL] [Abstract][Full Text] [Related]
11. Delivery of therapeutic miRNA using polymer-based formulation.
Ban E; Kwon TH; Kim A
Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
[TBL] [Abstract][Full Text] [Related]
12. Silencing of microRNAs in vivo with 'antagomirs'.
Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
[TBL] [Abstract][Full Text] [Related]
13. Antagonizing Increased
Vangoor VR; Reschke CR; Senthilkumar K; van de Haar LL; de Wit M; Giuliani G; Broekhoven MH; Morris G; Engel T; Brennan GP; Conroy RM; van Rijen PC; Gosselaar PH; Schorge S; Schaapveld RQJ; Henshall DC; De Graan PNE; Pasterkamp RJ
J Neurosci; 2019 Jun; 39(26):5064-5079. PubMed ID: 31015341
[TBL] [Abstract][Full Text] [Related]
14. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
15. Rapid bone repair with the recruitment of CD206
Castaño IM; Raftery RM; Chen G; Cavanagh B; Quinn B; Duffy GP; O'Brien FJ; Curtin CM
Acta Biomater; 2020 Jun; 109():267-279. PubMed ID: 32251781
[TBL] [Abstract][Full Text] [Related]
16. Cardiac injections of AntagomiRs as a novel tool for knockdown of miRNAs during heart development.
Wittig JG; Billmeier M; Lozano-Velasco E; García MR; Münsterberg AE
Dev Biol; 2019 Jan; 445(2):163-169. PubMed ID: 30496744
[TBL] [Abstract][Full Text] [Related]
17. Acid-Triggered Charge-Convertible Graphene-Based All-in-One Nanocomplex for Enhanced Genetic Phototherapy of Triple-Negative Breast Cancer.
Wu C; Tian Y; Zhang Y; Xu J; Wang Y; Guan X; Li T; Yang H; Li S; Qin X; Liu Y
Adv Healthc Mater; 2020 Jan; 9(1):e1901187. PubMed ID: 31800164
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice.
Ramirez-Moya J; Wert-Lamas L; Acuña-Ruiz A; Zaballos MA; Santisteban P
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31498304
[TBL] [Abstract][Full Text] [Related]
19. Specificity, duplex degradation and subcellular localization of antagomirs.
Krützfeldt J; Kuwajima S; Braich R; Rajeev KG; Pena J; Tuschl T; Manoharan M; Stoffel M
Nucleic Acids Res; 2007; 35(9):2885-92. PubMed ID: 17439965
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
